AI Agents
Desktop
API & Integration
Pricing
Blog
AI Agents
IP Search Agents
Novelty Search
FTO Search
Design FTO Search
IP Drafting Agents
SEP Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
SAR Data Extraction
Lead Compound
Materials Agents
Desktop
API & Integration
Pricing
Blog
IP Search Agents
Novelty Search
FTO Search
Design FTO Search
IP Drafting Agents
SEP Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
SAR Data Extraction
Lead Compound
Materials Agents
Eureka Desktop Now Available
Download now
Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.
3
results about "Cutaneous condition" patented technology
Filter
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
A temporary or permanent ailment of skin that may be contagious or non contagious.
Dosage regimen for using a topical roflumilast composition
Pending
CN122295098A
Dosing regimen
Disease
This method involves treating a patient's
skin
condition or
disease
by topically applying a pharmaceutical composition containing
roflumilast
. Treatment methods include once-daily application of the
roflumilast
composition for a period of time, followed by twice-weekly application of the
roflumilast
composition as a maintenance
dosing regimen
.
View all
Owner:
ARCUTIS BIOTHERAPEUTICS INC
Topical skin care compositions
Active
US12642834B2
Ointment delivery
Dermatological disorder
Physiology
Eczematous rash
Disclosed are compositions and their use for the treatment of
human skin
, particularly
facial skin
, to alleviate the symptoms of cosmetic or dermatologic
skin
conditions. The compositions include black
willow
bark
extract, cats claw extract, and dragon's blood extract. The compositions ameliorate
skin
conditions including
acne
,
rosacea
, blemish, dermatitis, eczema, or the like.
View all
Owner:
M & J PROPERTIES JOINT VENTURE
Topical compositions and regimens
PCT designated stage
WO2026147911A1
Hair loss
Pharmacology
The present disclosures provides new technologies for treatment and / or prevention of certain dermatological conditions, specifically including
hair loss
and hair graying. Among other things, the present disclosure provides an insight that topical compositions comprising
plasminogen activator
inhibitor -1 (PAI-1) inhibitors may be safe, effective, and efficient in the treatment and / or prevention of certain dermatological conditions, and in particular in treatment and / or prevention of
hair loss
and hair graying.
View all
Owner:
EIRION THERAPEUTICS INC
Login to View More
Popular searches
Regimen
Pharmaceutical drug
Pharmaceutical Substances
Medicinal chemistry
Skin care
Cutis
Human skin
Dermatologic disorders
Skin surfaces